Filing Details

Accession Number:
0001209191-17-001510
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-04 19:19:29
Reporting Period:
2016-12-15
Filing Date:
2017-01-04
Accepted Time:
2017-01-04 19:19:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
827871 Eagle Pharmaceuticals Inc. EGRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1599743 L. Steven Krill C/O Eagle Pharmaceuticals, Inc.
50 Tice Blvd., Suite 315
Woodcliff Lake NJ 07677
Evp & Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-15 3,730 $4.42 3,730 No 4 M Direct
Common Stock Disposition 2016-12-15 3,730 $74.79 0 No 4 S Direct
Common Stock Acquisiton 2016-12-15 6,270 $12.67 6,270 No 4 M Direct
Common Stock Disposition 2016-12-15 6,270 $74.79 0 No 4 S Direct
Common Stock Acquisiton 2016-12-19 2,683 $12.67 2,683 No 4 M Direct
Common Stock Disposition 2016-12-19 2,683 $75.61 0 No 4 S Direct
Common Stock Acquisiton 2016-12-19 7,317 $12.63 7,317 No 4 M Direct
Common Stock Disposition 2016-12-19 7,317 $75.61 0 No 4 S Direct
Common Stock Acquisiton 2016-12-20 10,000 $12.63 10,000 No 4 M Direct
Common Stock Disposition 2016-12-20 10,000 $76.69 0 No 4 S Direct
Common Stock Acquisiton 2016-12-21 2,683 $12.63 2,683 No 4 M Direct
Common Stock Disposition 2016-12-21 2,683 $77.17 0 No 4 S Direct
Common Stock Acquisiton 2016-12-21 7,569 $46.09 7,569 No 4 M Direct
Common Stock Disposition 2016-12-21 7,569 $77.17 0 No 4 S Direct
Common Stock Acquisiton 2016-12-22 5,126 $46.09 5,126 No 4 M Direct
Common Stock Disposition 2016-12-22 5,126 $76.78 0 No 4 S Direct
Common Stock Acquisiton 2016-12-23 5,127 $46.09 5,127 No 4 M Direct
Common Stock Disposition 2016-12-23 5,127 $78.61 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-12-15 3,730 $0.00 3,730 $4.42
Common Stock Stock Option (right to buy) Disposition 2016-12-15 6,270 $0.00 6,270 $12.67
Common Stock Stock Option (right to buy) Disposition 2016-12-19 2,683 $0.00 2,683 $12.67
Common Stock Stock Option (right to buy) Disposition 2016-12-19 7,317 $0.00 7,317 $12.63
Common Stock Stock Option (right to buy) Disposition 2016-12-20 10,000 $0.00 10,000 $12.63
Common Stock Stock Option (right to buy) Disposition 2016-12-21 2,683 $0.00 2,683 $12.63
Common Stock Stock Option (right to buy) Disposition 2016-12-21 7,569 $0.00 7,569 $46.09
Common Stock Stock Option (right to buy) Disposition 2016-12-22 5,126 $0.00 5,126 $46.09
Common Stock Stock Option (right to buy) Disposition 2016-12-23 5,127 $0.00 5,127 $46.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,480 2023-04-18 No 4 M Direct
11,635 2024-04-07 No 4 M Direct
8,952 2024-04-07 No 4 M Direct
32,683 2024-08-25 No 4 M Direct
22,683 2024-08-25 No 4 M Direct
20,000 2024-08-25 No 4 M Direct
63,717 2025-03-12 No 4 M Direct
58,591 2025-03-12 No 4 M Direct
53,464 2025-03-12 No 4 M Direct
Footnotes
  1. 25% of the shares subject to the option vested on April 19, 2014 and the remainder shall vest in equal monthly installments over a period of three years.
  2. 25% of the shares subject to the option vested on April 8, 2015 and the remainder shall vest in equal monthly installments over a period of three years.
  3. 25% of the shares subject to the option vested on August 26, 2015 and the remainder shall vest in equal monthly installments over a period of three years.
  4. 25% of the shares subject to the option vested on March 13, 2016 and the remainder shall vest in equal monthly installments over a period of three years.